Dwarfism: all 99 studies
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Open-Label, Long-Term, Extension Study of Infigratinib in Children With HypochondroplasiaEnrolling by invitationNCT07393373Phase 2
- Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersRecruitingNCT07221851Phase 3
- Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)RecruitingNCT07169279Phase 2
- An Interventional Study of Infigratinib in Children With HypochondroplasiaEnrolling by invitationNCT06873035Phase 2/3
- The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal ChildrenNot yet recruitingNCT06768411Not applicable
- Prospective Clinical Assessment Study in Children With HypochondroplasiaRecruitingNCT06410976
- Oral Manifestations in Egyptian Children With Short StatureNot yet recruitingNCT06372366
- A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With AchondroplasiaEnrolling by invitationNCT05929807Phase 2/3
- Vosoritide for Short Stature in Turner SyndromeRecruitingNCT05849389Phase 2
- A Natural History Study in Children With a Type II Collagen Disorder With Short StatureRecruitingNCT05408715
- Non-invasive Functional Assessment and Pathogenesis of Morquio ARecruitingNCT05284006
- Study of Skeletal DisordersRecruitingNCT05031507
- Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in AchondroplasiaTerminatedNCT05116046Phase 2Results posted
- A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With AchondroplasiaCompletedNCT04085523Phase 2Results posted
- A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With AchondroplasiaCompletedNCT03583697Phase 2Results posted
- Growth Hormone Treatment in Patients With Aggrecan (ACAN) DeficiencyCompletedNCT03288103Phase 1/2Results posted
- A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With AchondroplasiaCompletedNCT03197766Phase 3Results posted
- Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in ChildrenCompletedNCT02879747Phase 2/3Results posted
- IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 DeficiencyCompletedNCT02636270Phase 1/2Results posted
- Aromatase Inhibitor Growth Study: Letrozole vs. AnastrozoleCompletedNCT02137538Phase 4Results posted
- A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With AchondroplasiaCompletedNCT02055157Phase 2Results posted
- Weekly Zinc Chelate Supplementation on Children's GrowthCompletedNCT01911260Phase 2/3Results posted
- Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)CompletedNCT01859949Phase 4Results posted
- Free Fatty Acids, Body Weight, and Growth Hormones Secretion in ChildrenTerminatedNCT01237041Phase 1/2Results posted
- Ghrelin Levels in Children With Poor GrowthCompletedNCT01070173Results posted
- Clinical Trial of Growth Hormone in MPS I, II, and VITerminatedNCT00748969Phase 2/3Results posted
- Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's DiseaseTerminatedNCT00511329Phase 2/3Results posted
- Growth Hormone and Endothelial Function in ChildrenCompletedNCT00373386Phase 4Results posted
- Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 DeficiencyTerminatedNCT00330668Phase 3Results posted
- Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAqCompletedNCT00234533Phase 3Results posted
- A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in BloodCompletedNCT00212758Phase 4Results posted
- Somatropin Treatment to Final Height in Turner SyndromeCompletedNCT00191113Phase 3Results posted
- A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentActive, not recruitingNCT06668805Phase 2
- Interventional Study of Vosoritide for the Treatment of Children With HypochondroplasiaActive, not recruitingNCT06455059Phase 3
- Short Stature and Psychological Well-beingCompletedNCT06295341
- Biological Age in Children With GH Deficiency Undergoing Hormone Replacement TherapyCompletedNCT06294860
- A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With AchondroplasiaCompletedNCT06164951Phase 3
- A Trial of YPEG-rhGH in Children With Short StatureCompletedNCT05838885Phase 2
- Testing the Feasibility of a Novel Growth Monitoring Smartphone AppCompletedNCT05829252
- Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)CompletedNCT05759624
- The Effect of Myofascial Release Technique on Sportive Performance, Balance and Injury Risk in RunnersStatus unknownNCT05392153Not applicable
- A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With AchondroplasiaCompletedNCT05246033Phase 2
- Hypo-mineralization of Primary and Permanent Teeth in a Group of Children With Stunted Growth.A Cross Sectional Study.Status unknownNCT04774653
- Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting PatientsCompletedNCT04754516
- A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With AchondroplasiaActive, not recruitingNCT04554940Phase 2
- Intervention in Chronic Pediatric Patients and Their Families.CompletedNCT04476433Not applicable
- Mauriac Syndrome: Isotopic Techniques and Genetic AnalysisCompletedNCT04275141Not applicable
- Study of Infigratinib in Children With AchondroplasiaCompletedNCT04265651Phase 2
- Web-based Adherence Information Integrated Nurse-led Monitoring ClinicCompletedNCT04244123
- Nutritional Stimulation of Growth in Children With Short StatureCompletedNCT04226586Not applicable
- Vosoritide for Selected Genetic Causes of Short StatureActive, not recruitingNCT04219007Phase 2
- Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)CompletedNCT04035811
- Skeletal Muscle Effects of GH in BoysCompletedNCT04020913
- An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With AchondroplasiaActive, not recruitingNCT03989947Phase 2
- A Multi-center, Longitudinal, Observational Study of Children With AchondroplasiaCompletedNCT03875534
- Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISSStatus unknownNCT03635580Phase 3
- Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype CorrelationCompletedNCT03575221
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before TransplantationStatus unknownNCT03535415Phase 3
- An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With AchondroplasiaActive, not recruitingNCT03424018Phase 3
- Long Term Effects of Nutritional Supplementation on Final HeightWithdrawnNCT03323177Not applicable
- A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short StatureActive, not recruitingNCT03255694Phase 2
- A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short StatureStatus unknownNCT03221088Phase 2
- Growth Hormone (GH) in Congenital Adrenal HyperplasiaCompletedNCT03162172
- Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-rayStatus unknownNCT03123003Not applicable
- Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.CompletedNCT03015909Phase 4
- Fitness Level in Short Stature Children and After Growth Hormone TreatmentStatus unknownNCT02977091
- Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled TrialCompletedNCT02826902Not applicable
- A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)Active, not recruitingNCT02724228Phase 2
- Pappalysin 2 (PAPP-A2) Enzyme ReplacementCompletedNCT02412943Phase 1
- Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents BoysCompletedNCT02389803Not applicable
- Genetic Causes of Growth DisordersTerminatedNCT02311322
- Versartis Long-Term Safety Study of SomavaratanTerminatedNCT02068521Phase 2/3
- The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short StatureWithdrawnNCT01970800Not applicable
- Growth Hormone Secretion Following the Anaerobic ExerciseStatus unknownNCT01934270Not applicable
- Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In RemissionStatus unknownNCT01901666Phase 4
- A Clinical Study to Assess the Efficacy and Safety of DA-3002CompletedNCT01813630Phase 3
- A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With AchondroplasiaCompletedNCT01603095
- C-Type Natriuretic Peptide and AchondroplasiaCompletedNCT01541306
- Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic PatientsCompletedNCT01328418Not applicable
- A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to AdulthoodCompletedNCT01157793Phase 4
- Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne SyndromeCompletedNCT01142154Phase 1/2
- Three Times Weekly (TIW) Growth Hormone Therapy in Children on HemodialysisCompletedNCT00943995Phase 3
- Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in ChildrenCompletedNCT00830141
- IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of IncrelexTerminatedNCT00747604
- Effects of Growth Hormone (GH) Treatment on Eating RegulationCompletedNCT00562705Not applicable
- Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone DeficiencyCompletedNCT00489294Phase 1
- Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With SomatropinCompletedNCT00488124Phase 2
- rhGH Therapy on Hepatic Drug MetabolismCompletedNCT00458991
- D3-GHR Polymorphism and Turner SyndromeCompletedNCT00443144
- The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.CompletedNCT00235599
- Nutrients and Hormones: Effects in Boys With Disordered GrowthCompletedNCT00139451Phase 2
- Arimidex Multicenter Trial in Growth Hormone (GH) Deficient BoysCompletedNCT00133354Phase 2/3
- Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short StatureTerminatedNCT00121875
- Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low BirthweightStatus unknownNCT00120497
- Role of Nutrition and Hormones in Boys With Disordered GrowthCompletedNCT00102258Phase 2
- Study of Skeletal Disorders and Short StatureCompletedNCT00001754
- Issues Surrounding Prenatal Genetic Testing for AchondroplasiaCompletedNCT00001536
- The Effects of Hormones in Growth Hormone-Treated Girls With Turner SyndromeCompletedNCT00001343Phase 2
- Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short StatureCompletedNCT00001190Phase 2